Adiponectin-Resistance in Obesity.

[1]  M. Yamakuchi,et al.  HMGB1 is secreted by 3T3‐L1 adipocytes through JNK signaling and the secretion is partially inhibited by adiponectin , 2016, Obesity.

[2]  Steven R Smith,et al.  Low expression of the GILZ may contribute to adipose inflammation and altered adipokine production in human obesity , 2016, Journal of Lipid Research.

[3]  C. Calaminus,et al.  PI3K-resistant GSK3 controls adiponectin formation and protects from metabolic syndrome , 2016, Proceedings of the National Academy of Sciences.

[4]  H. Ruan,et al.  Adiponectin signaling and function in insulin target tissues , 2016, Journal of molecular cell biology.

[5]  K. Siddle,et al.  Acute knockdown of the insulin receptor or its substrates Irs1 and 2 in 3T3-L1 adipocytes suppresses adiponectin production , 2016, Scientific Reports.

[6]  X. Norel,et al.  Human perivascular adipose tissue dysfunction as a cause of vascular disease: Focus on vascular tone and wall remodeling. , 2015, European journal of pharmacology.

[7]  C. Vrints,et al.  Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failure , 2015, Journal of cachexia, sarcopenia and muscle.

[8]  E. Barrett,et al.  Globular adiponectin ameliorates metabolic insulin resistance via AMPK‐mediated restoration of microvascular insulin responses , 2015, The Journal of physiology.

[9]  M. Jensen,et al.  Differential effects of leptin on adiponectin expression with weight gain versus obesity , 2015, International Journal of Obesity.

[10]  T. Kamarul,et al.  The prevention and treatment of hypoadiponectinemia-associated human diseases by up-regulation of plasma adiponectin. , 2015, Life sciences.

[11]  S. Kwak,et al.  Obesity-induced DNA hypermethylation of the adiponectin gene mediates insulin resistance , 2015, Nature Communications.

[12]  Won-Young Lee,et al.  Adiponectin deletion impairs insulin signaling in insulin-sensitive but not insulin-resistant 3T3-L1 adipocytes. , 2015, Life sciences.

[13]  M. Burtscher,et al.  Hypoxia, Oxidative Stress and Fat , 2015, Biomolecules.

[14]  M. Hegazy,et al.  Combined Adiponectin Deficiency and Resistance in Obese Patients: Can It Solve Part of the Puzzle in Nonalcoholic Steatohepatitis , 2015, Open access Macedonian journal of medical sciences.

[15]  S. Yokoyama,et al.  Crystal structures of the human adiponectin receptors , 2015, Nature.

[16]  R. Charnigo,et al.  Increasing Adipocyte Lipoprotein Lipase Improves Glucose Metabolism in High Fat Diet-induced Obesity* , 2015, The Journal of Biological Chemistry.

[17]  G. Sweeney,et al.  Palmitate Induces ER Stress and Autophagy in H9c2 Cells: Implications for Apoptosis and Adiponectin Resistance , 2015, Journal of cellular physiology.

[18]  T. Villarreal-Molina,et al.  Role of adiponectin and free fatty acids on the association between abdominal visceral fat and insulin resistance , 2015, Cardiovascular Diabetology.

[19]  A. J. Lusis,et al.  Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti‐inflammatory response , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  M. Hou,et al.  A high-fat maternal diet decreases adiponectin receptor-1 expression in offspring , 2015, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[21]  H. Randeva,et al.  Differential Effects of Leptin and Adiponectin in Endothelial Angiogenesis , 2015, Journal of diabetes research.

[22]  C. Caselli.  Role of adiponectin system in insulin resistance. , 2014, Molecular genetics and metabolism.

[23]  S. Ding,et al.  Adiponectin receptor 1 overexpression reduces lipid accumulation and hypertrophy in the heart of diet-induced obese mice – possible involvement of oxidative stress and autophagy , 2014, Endocrine research.

[24]  P. Matafome,et al.  Long-term globular adiponectin administration improves adipose tissue dysmetabolism in high-fat diet-fed Wistar rats , 2014, Archives of physiology and biochemistry.

[25]  P. Marzullo,et al.  Inherent insulin sensitivity is a major determinant of multimeric adiponectin responsiveness to short-term weight loss in extreme obesity , 2014, Scientific Reports.

[26]  D. Cameron-Smith,et al.  3T3-L1 Preadipocytes Exhibit Heightened Monocyte-Chemoattractant Protein-1 Response to Acute Fatty Acid Exposure , 2014, PloS one.

[27]  Feng Dong,et al.  APPL1 Potentiates Insulin Sensitivity by Facilitating the Binding of IRS1/2 to the Insulin Receptor , 2014, Cell reports.

[28]  Kazuto Nakamura,et al.  Divergent Roles for Adiponectin Receptor 1 (AdipoR1) and AdipoR2 in Mediating Revascularization and Metabolic Dysfunction in Vivo* , 2014, The Journal of Biological Chemistry.

[29]  P. López-Jaramillo,et al.  The role of leptin/adiponectin ratio in metabolic syndrome and diabetes , 2014, Hormone molecular biology and clinical investigation.

[30]  S. Ding,et al.  Adiponectin receptor 1 enhances fatty acid metabolism and cell survival in palmitate-treated HepG2 cells through the PI3 K/AKT pathway , 2014, European Journal of Nutrition.

[31]  M. Matsuda,et al.  Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases , 2014, Reviews in Endocrine and Metabolic Disorders.

[32]  Yajing Wang,et al.  Adiponectin Inhibits Tumor Necrosis Factor-&agr;–Induced Vascular Inflammatory Response via Caveolin-Mediated Ceramidase Recruitment and Activation , 2014, Circulation research.

[33]  T. Aprahamian.  Elevated adiponectin expression promotes adipose tissue vascularity under conditions of diet-induced obesity. , 2013, Metabolism: clinical and experimental.

[34]  K. Matsuda,et al.  A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity , 2013, Nature.

[35]  P. Scherer,et al.  Dichotomous roles of leptin and adiponectin as enforcers against lipotoxicity during feast and famine , 2013, Molecular biology of the cell.

[36]  G. Paolisso,et al.  Association of Genetic Variation in Adaptor Protein APPL1/APPL2 Loci with Non-Alcoholic Fatty Liver Disease , 2013, PloS one.

[37]  Songtao Li,et al.  Inhibition of ERK1/2 pathway suppresses adiponectin secretion via accelerating protein degradation by Ubiquitin-proteasome system: relevance to obesity-related adiponectin decline. , 2013, Metabolism: clinical and experimental.

[38]  P. Scherer,et al.  Adiponectin, driver or passenger on the road to insulin sensitivity? , 2013, Molecular metabolism.

[39]  R. Henry,et al.  Adipose tissue depot and cell size dependency of adiponectin synthesis and secretion in human obesity , 2013, Adipocyte.

[40]  B. Frohnert,et al.  Protein carbonylation, mitochondrial dysfunction, and insulin resistance. , 2013, Advances in nutrition.

[41]  J. Wojtaszewski,et al.  Adiponectin concentration is associated with muscle insulin sensitivity, AMPK phosphorylation, and ceramide content in skeletal muscles of men but not women. , 2013, Journal of applied physiology.

[42]  N. Turner,et al.  Overexpression of the Adiponectin Receptor AdipoR1 in Rat Skeletal Muscle Amplifies Local Insulin Sensitivity , 2012, Endocrinology.

[43]  T. Griffin,et al.  Protein Carbonylation and Adipocyte Mitochondrial Function* , 2012, The Journal of Biological Chemistry.

[44]  G. Nolen,et al.  Effect of endoplasmic reticulum stress on inflammation and adiponectin regulation in human adipocytes. , 2012, Metabolic syndrome and related disorders.

[45]  Ki-Up Lee,et al.  Mitochondrial dysfunction and activation of iNOS are responsible for the palmitate-induced decrease in adiponectin synthesis in 3T3L1 adipocytes , 2012, Experimental & Molecular Medicine.

[46]  Li-na Han,et al.  Adiponectin improves endothelial dysfunction caused by elevated FFAs levels, partially through cAMP-dependent pathway. , 2012, Diabetes research and clinical practice.

[47]  Bonggi Lee,et al.  Adiponectin Increases Skeletal Muscle Mitochondrial Biogenesis by Suppressing Mitogen-Activated Protein Kinase Phosphatase-1 , 2012, Diabetes.

[48]  M. Jensen,et al.  Sphingolipid content of human adipose tissue: relationship to adiponectin and insulin resistance , 2012, Obesity.

[49]  M. Quon,et al.  Globular adiponectin counteracts VCAM-1-mediated monocyte adhesion via AdipoR1/NF-κB/COX-2 signaling in human aortic endothelial cells. , 2011, American journal of physiology. Endocrinology and metabolism.

[50]  Hong Wang,et al.  The Multi-Level Action of Fatty Acids on Adiponectin Production by Fat Cells , 2011, PloS one.

[51]  Yajing Wang,et al.  Systemic adiponectin malfunction as a risk factor for cardiovascular disease. , 2011, Antioxidants & redox signaling.

[52]  Xinhua Xiao,et al.  Adiponectin protects endothelial cells from the damages induced by the intermittent high level of glucose , 2011, Endocrine.

[53]  K. Lam,et al.  Cross‐talk between adipose tissue and vasculature: role of adiponectin , 2011, Acta physiologica.

[54]  F. Contaldo,et al.  High Leptin/Adiponectin Ratio and Serum Triglycerides Are Associated With an “At‐Risk” Phenotype in Young Severely Obese Patients , 2011, Obesity.

[55]  J. Gajewska,et al.  Changes in concentration of serum adiponectin multimeric forms following weight reduction programme in prepubertal obese children. , 2011, Medycyna wieku rozwojowego.

[56]  H. Leu,et al.  Globular adiponectin improves high glucose-suppressed endothelial progenitor cell function through endothelial nitric oxide synthase dependent mechanisms. , 2011, Journal of molecular and cellular cardiology.

[57]  N. Turner,et al.  The adaptor protein APPL1 increases glycogen accumulation in rat skeletal muscle through activation of the PI3-kinase signalling pathway , 2011, The Journal of endocrinology.

[58]  C. Buechler,et al.  Globular and full-length adiponectin induce NO-dependent vasodilation in resistance arteries of Zucker lean but not Zucker diabetic fatty rats. , 2011, American journal of hypertension.

[59]  C. Apovian,et al.  Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans. , 2011, Biochemical and biophysical research communications.

[60]  P. Ruiz-Lozano,et al.  T-cadherin is critical for adiponectin-mediated cardioprotection in mice. , 2010, The Journal of clinical investigation.

[61]  In-kyu Lee,et al.  Rosiglitazone promotes fatty acyl CoA accumulation and excessive glycogen storage in livers of mice without adiponectin. , 2010, Journal of hepatology.

[62]  A. Kahraman,et al.  Obesity Affects the Liver – The Link between Adipocytes and Hepatocytes , 2010, Digestion.

[63]  F. Thong,et al.  An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart. , 2010, American journal of physiology. Endocrinology and metabolism.

[64]  M. Birnbaum,et al.  The Pleiotropic Actions of Adiponectin are Initiated via Receptor-Mediated Activation of Ceramidase Activity , 2010, Nature Medicine.

[65]  Hyun Jin Park,et al.  ATF3 negatively regulates adiponectin receptor 1 expression. , 2010, Biochemical and biophysical research communications.

[66]  Yajing Wang,et al.  Reduced vascular responsiveness to adiponectin in hyperlipidemic rats--mechanisms and significance. , 2010, Journal of molecular and cellular cardiology.

[67]  E. Henriksen.  Dysregulation of glycogen synthase kinase-3 in skeletal muscle and the etiology of insulin resistance and type 2 diabetes. , 2010, Current diabetes reviews.

[68]  W. Lau,et al.  Adiponectin resistance and vascular dysfunction in the hyperlipidemic state , 2010, Acta Pharmacologica Sinica.

[69]  G. Egeland,et al.  Plasma fatty acids and desaturase activity are associated with circulating adiponectin in healthy adolescent girls. , 2010, The Journal of clinical endocrinology and metabolism.

[70]  T. Kizaki,et al.  Effect of exercise training on adipocyte-size-dependent expression of leptin and adiponectin. , 2010, Life sciences.

[71]  K. Walsh,et al.  Adiponectin Promotes Macrophage Polarization toward an Anti-inflammatory Phenotype* , 2009, The Journal of Biological Chemistry.

[72]  U. Garbin,et al.  The effects of adiponectin on interleukin-6 and MCP-1 secretion in lipopolysaccharide-treated 3T3-L1 adipocytes: role of the NF-kappaB pathway. , 2009, International journal of molecular medicine.

[73]  S. Bernard,et al.  Adipocyte Turnover: Relevance to Human Adipose Tissue Morphology , 2009, Diabetes.

[74]  A. Pfeiffer,et al.  Acute hyperinsulinaemia and hyperlipidaemia modify circulating adiponectin and its oligomers , 2009, Clinical endocrinology.

[75]  T. Murohara,et al.  Adiponectin and cardiovascular disease. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[76]  Zhenzhen Wang,et al.  Endocytosis of adiponectin receptor 1 through a clathrin- and Rab5-dependent pathway , 2009, Cell Research.

[77]  A. Tchernof,et al.  Fat Depot‐specific Impact of Visceral Obesity on Adipocyte Adiponectin Release in Women , 2009, Obesity.

[78]  Yajing Wang,et al.  Endothelial dysfunction in adiponectin deficiency and its mechanisms involved. , 2009, Journal of molecular and cellular cardiology.

[79]  A. Bonen,et al.  Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[80]  Peng Zhang,et al.  Overexpression of Adiponectin Receptors Potentiates the Antiinflammatory Action of Subeffective Dose of Globular Adiponectin in Vascular Endothelial Cells , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[81]  T. Kadowaki,et al.  Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases , 2008, International Journal of Obesity.

[82]  Haiyan Xu,et al.  Obesity-Related Upregulation of Monocyte Chemotactic Factors in Adipocytes , 2008, Diabetes.

[83]  M. Prentki,et al.  Obese Mice Lacking Inducible Nitric Oxide Synthase Are Sensitized to the Metabolic Actions of Peroxisome Proliferator–Activated Receptor-γ Agonism , 2008, Diabetes.

[84]  S. Summers,et al.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. , 2008, Endocrine reviews.

[85]  Min-Seon Kim,et al.  Essential Role of Mitochondrial Function in Adiponectin Synthesis in Adipocytes , 2007, Diabetes.

[86]  F. Gao,et al.  Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity. , 2007, American journal of physiology. Endocrinology and metabolism.

[87]  B. Viollet,et al.  Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders. , 2007, Diabetes & metabolism.

[88]  Daisuke Fujioka,et al.  Statin reverses reduction of adiponectin receptor expression in infarcted heart and in TNF-alpha-treated cardiomyocytes in association with improved glucose uptake. , 2007, American journal of physiology. Heart and circulatory physiology.

[89]  M. Czech,et al.  The Interaction of Akt with APPL1 Is Required for Insulin-stimulated Glut4 Translocation* , 2007, Journal of Biological Chemistry.

[90]  M. Broch,et al.  Effect of weight loss induced by gastric bypass on proinflammatory interleukin‐18, soluble tumour necrosis factor‐α receptors, C‐reactive protein and adiponectin in morbidly obese patients , 2007 .

[91]  Hua V. Lin,et al.  Adiponectin Resistance Exacerbates Insulin Resistance in Insulin Receptor Transgenic/Knockout Mice , 2007, Diabetes.

[92]  D. Dyck,et al.  Globular adiponectin resistance develops independently of impaired insulin-stimulated glucose transport in soleus muscle from high-fat-fed rats. , 2007, American journal of physiology. Endocrinology and metabolism.

[93]  C. Burant,et al.  Role of FoxO1 in FFA-induced oxidative stress in adipocytes. , 2007, American journal of physiology. Endocrinology and metabolism.

[94]  G. Ramponi,et al.  Redox‐dependent and ligand‐independent trans‐activation of insulin receptor by globular adiponectin , 2007, Hepatology.

[95]  Z. Qian,et al.  Crocetin attenuates palmitate‐induced insulin insensitivity and disordered tumor necrosis factor‐α and adiponectin expression in rat adipocytes , 2007, British journal of pharmacology.

[96]  D. Dunger,et al.  Paradoxical Elevation of High–Molecular Weight Adiponectin in Acquired Extreme Insulin Resistance Due to Insulin Receptor Antibodies , 2007, Diabetes.

[97]  Walter Koch,et al.  Adiponectin Cardioprotection After Myocardial Ischemia/Reperfusion Involves the Reduction of Oxidative/Nitrative Stress , 2007, Circulation.

[98]  P. Froguel,et al.  Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions , 2007, Nature Medicine.

[99]  B. Kemp,et al.  Differential Regulation of Adiponectin Receptor Gene Expression by Adiponectin and Leptin in Myotubes Derived from Obese and Diabetic Individuals , 2006, Obesity.

[100]  E. Henriksen,et al.  Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes. , 2006, Current drug targets.

[101]  B. Kemp,et al.  The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans. , 2006, The Journal of clinical endocrinology and metabolism.

[102]  J. Shiloach,et al.  MKR mice are resistant to the metabolic actions of both insulin and adiponectin: discordance between insulin resistance and adiponectin responsiveness. , 2006, American journal of physiology. Endocrinology and metabolism.

[103]  E. Henriksen,et al.  Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats. , 2006, American journal of physiology. Endocrinology and metabolism.

[104]  S. O’Rahilly,et al.  Elevated plasma adiponectin in humans with genetically defective insulin receptors. , 2006, The Journal of clinical endocrinology and metabolism.

[105]  J. Olefsky,et al.  APPLied mechanics: uncovering how adiponectin modulates insulin action. , 2006, Cell metabolism.

[106]  A. Lacy,et al.  Intra-abdominal Fat Adiponectin Receptors Expression and Cardiovascular Metabolic Risk Factors in Obesity and Diabetes , 2006, Obesity surgery.

[107]  H. Motoshima,et al.  Adiponectin Suppression of High-Glucose–Induced Reactive Oxygen Species in Vascular Endothelial Cells , 2006, Diabetes.

[108]  R. Kitazawa,et al.  MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. , 2006, The Journal of clinical investigation.

[109]  J. Whitehead,et al.  Adiponectin – a key adipokine in the metabolic syndrome , 2006, Diabetes, obesity & metabolism.

[110]  Feng Liu,et al.  APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function , 2006, Nature Cell Biology.

[111]  R. Leibel,et al.  CCR2 modulates inflammatory and metabolic effects of high-fat feeding. , 2006, The Journal of clinical investigation.

[112]  S. B. Pedersen,et al.  Adiponectin Receptors in Human Adipose Tissue: Effects of Obesity, Weight Loss, and Fat Depots , 2006, Obesity.

[113]  G. Heigenhauser,et al.  The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects. , 2005, Diabetes.

[114]  G. Baffy.  Uncoupling protein-2 and non-alcoholic fatty liver disease. , 2005, Frontiers in bioscience : a journal and virtual library.

[115]  D. Accili,et al.  FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. , 2005, Cell metabolism.

[116]  M. Suwa,et al.  The leptin to adiponectin ratio is a good biomarker for the prevalence of metabolic syndrome, dependent on visceral fat accumulation and endurance fitness in obese patients with diabetes mellitus. , 2005, Metabolic syndrome and related disorders.

[117]  William C Stanley,et al.  Myocardial substrate metabolism in the normal and failing heart. , 2005, Physiological reviews.

[118]  A. Pfeiffer,et al.  Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women , 2005, International Journal of Obesity.

[119]  B. Kemp,et al.  Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. , 2005, The Journal of clinical endocrinology and metabolism.

[120]  T. Kadowaki,et al.  Adiponectin and adiponectin receptors. , 2005, Endocrine reviews.

[121]  S. Brichard,et al.  Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies. , 2004, Endocrinology.

[122]  Sarah Yoon,et al.  CCAAT/enhancer binding protein and nuclear factor-Y regulate adiponectin gene expression in adipose tissue. , 2004, Diabetes.

[123]  S. Kihara,et al.  Adiponectin as a biomarker of the metabolic syndrome. , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[124]  P. Froguel,et al.  Insulin/Foxo1 Pathway Regulates Expression Levels of Adiponectin Receptors and Adiponectin Sensitivity* , 2004, Journal of Biological Chemistry.

[125]  H. Lodish,et al.  T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[126]  G. Mingrone,et al.  Restoration of adiponectin pulsatility in severely obese subjects after weight loss. , 2004, Diabetes.

[127]  H. Motoshima,et al.  Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. , 2004, Biochemical and biophysical research communications.

[128]  N. Gungor,et al.  Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. , 2004, Diabetes care.

[129]  B. Staels,et al.  Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR. , 2004, Biochemical and biophysical research communications.

[130]  S. Kihara,et al.  Adiponectin Stimulates Angiogenesis by Promoting Cross-talk between AMP-activated Protein Kinase and Akt Signaling in Endothelial Cells* , 2004, Journal of Biological Chemistry.

[131]  H. Lodish,et al.  Role of Disulfide Bonds in Acrp30/Adiponectin Structure and Signaling Specificity , 2003, Journal of Biological Chemistry.

[132]  Hui Chen,et al.  Adiponectin Stimulates Production of Nitric Oxide in Vascular Endothelial Cells* , 2003, Journal of Biological Chemistry.

[133]  P. Froguel,et al.  Impaired Multimerization of Human Adiponectin Mutants Associated with Diabetes , 2003, Journal of Biological Chemistry.

[134]  S. Toubro,et al.  Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. , 2003, American journal of physiology. Endocrinology and metabolism.

[135]  B. Song,et al.  A glucocorticoid‐induced leucine‐zipper protein, GILZ, inhibits adipogenesis of mesenchymal cells , 2003, EMBO reports.

[136]  J. Engel,et al.  Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin , 2003, The Journal of Biological Chemistry.

[137]  H. Motoshima,et al.  Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. , 2002, The Journal of clinical endocrinology and metabolism.

[138]  H. Lodish,et al.  Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl–CoA carboxylase inhibition and AMP-activated protein kinase activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[139]  S. Zolotukhin,et al.  Regulation of adiponectin and leptin gene expression in white and brown adipose tissues: influence of beta3-adrenergic agonists, retinoic acid, leptin and fasting. , 2002, Biochimica et biophysica acta.

[140]  C. Kahn,et al.  Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. , 2002, Developmental cell.

[141]  T Nakamura,et al.  Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. , 1999, Circulation.

[142]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[143]  B. Spiegelman,et al.  AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*) , 1996, The Journal of Biological Chemistry.

[144]  Philipp E. Scherer,et al.  A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.

[145]  P. Kaminski,et al.  NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. , 1994, The American journal of physiology.

[146]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[147]  M. Fasshauer,et al.  Leptin dose-dependently decreases atherosclerosis by attenuation of hypercholesterolemia and induction of adiponectin. , 2016, Biochimica et biophysica acta.

[148]  T. Kadowaki,et al.  Adiponectin receptors: a review of their structure, function and how they work. , 2014, Best practice & research. Clinical endocrinology & metabolism.

[149]  K. Hino,et al.  Screening for adiponectin secretion regulators. , 2012, Vitamins and hormones.

[150]  Q. Cui,et al.  Insulin decreases myocardial adiponectin receptor 1 expression via PI3K/Akt and FoxO1 pathway. , 2012, Cardiovascular research.

[151]  G. Kovacs,et al.  Relationship of adipokines and non-esterified fatty acid to the insulin resistance in non-diabetic individuals , 2011, Journal of endocrinological investigation.

[152]  Xinliang Ma,et al.  Protective vascular and myocardial effects of adiponectin , 2009, Nature Clinical Practice Cardiovascular Medicine.

[153]  Lily Q. Dong,et al.  APPL1: role in adiponectin signaling and beyond. , 2009, American journal of physiology. Endocrinology and metabolism.

[154]  R. Somwar,et al.  Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells , 2004, Diabetologia.

[155]  P. Arner,et al.  Lipolysis in human adipocytes, effects of cell size, age and of regional differences. , 1988, Hormone and metabolic research. Supplement series.

[156]  T. Funahashi,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .